Skip to main content

Table 1 Distribution of specific KRAS mutations in 17 cases

From: Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer

Mutation Amino acid N % %
GGT → GAT gly12 → asp12 5   29
GGT → TGT gly12 → cys12 1   6
GGT → GTT Gly12 → val12 5   29
GGT → GCT gly12 → alanin12 2   12
GGT → AGT gly12 → ser12 2   12
GGT → CGT gly12 → arg12 1   6
GGT → GAC gly13 → asp13 1   6
  Total 17   100